Maharashtra FDA seizes ₹1.56 crore worth of food stock in statewide drive

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.

• Amgen reported $36.7B revenue in FY 2025, 10% growth, 21% net margin
• Johnson & Johnson reported $94.2B revenue in FY 2025, 6% growth, 28.5% net margin
• Johnson & Johnson has lower debt-to-equity ratio (0.6x) vs Amgen's 6.3x

3h ago ·fool.com

Grayscale's New Zcash ETF Has Gathered $1 Billion in Assets in Just 30 Days. Here's Why Investors Are So Bullish on Zcash.

The privacy coin has been a standout performer in a tough crypto market.

• Grayscale's new Zcash ETF amassed $1 billion in assets in 30 days.
• Zcash's value surged 149% in the same period, becoming the leading privacy coin.
• Zcash offers both transparent and shielded addresses using zk-SNARKs for transaction privacy.

3h ago ·fool.com

Prediction: 2 Stocks That Will Be Worth More Than IonQ 5 Years From Now

IonQ is the most famous quantum stock on the market, and it is worth $12.5 billion. One satellite imaging company and one nuclear start-up could both pass it by 2031.

• Planet Labs, satellite imaging firm, valued at $5 billion
• 58% revenue growth, 100+ satellites, 2-year contract backlog
• Oklo, small fast-fission reactor company, potential $13B valuation

3h ago ·fool.com

Treasury Market Gets to Breathe: AI Companies Front-Loaded Debt Sales and, Loaded with Massive Cash to Spend, Step Back from the Bond Market

Conniptions in the Treasury Market calm down. Nothing Goes to Heck in a Straight Line , says the WOLF STREET dictum, not even the Treasury Market.

3h ago ·wolfstreet.com